|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61K 31/713 | (2006.01) | ||
| C12N 15/11 | (2006.01) | ||
| C07H 21/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| C12N 15/113 | (2010.01) |
| (11) | Number of the document | 2399611 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10181204.8 |
| Date of filing the European patent application | 2005-02-28 | |
| (97) | Date of publication of the European application | 2011-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 558135 P | 2004-04-01 | US | |
| 04004478 | 2004-02-27 | EP |
| (72) |
Schlingensiepen, Karl-Hermann, Dr., DE
Schlingensiepen, Reimar, Dr., DE
Jachimczak, Piotr, Dr., DE
Hafner, Michael, Dr., DE
Bischof, Astrid, Dr., DE
Bauer, Tamara, Dr. (geboren Egger), CH
Stauder, Gerhard, Dr., DE
|
| (73) |
Autotelic LLC,
17870 Castleton Street, Suite 250, City of Industry, CA 91748,
US
|
| (54) | USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATON OF METASATASES IN CANCER TREATMENT |
| USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATON OF METASATASES IN CANCER TREATMENT |